In addition to therapeutic options such as steroid ointment, immunosuppressive drugs and ultraviolet phototherapy, recent reports have demonstrated the clinical efficacy of topical vitamin D
3 for vitiligo vulgaris. However, there seems to be little clinical effect of vitamin D
3 without combination of ultraviolet exposure. In the present study, we evaluated the clinical difference of sun illumination versus narrowband UVB in combination with topical tacalcitol by assessing the change of lesion size and that of color tone by a spectrophotometer. Thirty-three vitiligo patients were composed of 19 treated with sun illumination and 14 treated with narrowband UVB accompanied by topical tacalcitol. The mean percent size reduction was higher in the group treated with sun illumination than the narrowband UVB treated group (29% vs 23%). Delta L score, which represented the difference of whiteness between lesional and perilesional skin, was decreased shortly with the combination of tacalcitol and sunbathing but not with narrowband UVB (p=0.0906). Taken together, we consider that sun illumination after topical tacalcitol administration may induce natural repigmentation and be an alternative therapeutic option for vitiligo vulgaris. Skin Research, 10: 485-493, 2011
View full abstract